Detected ·
Delix Therapeutics
——
UC Davis Health Ventures' IFM Fund made a follow-on investment in Delix Therapeutics to advance Zalsupindole, an investigational oral medicine for major depressive disorder.
- Website
- —
- linkedin.com/company/76400524
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-11-13 08:06:38 UTC
- Signal ID
- fc1899af-acc5-406a-85c6-b9ea497a9b06
As the API returns it
{
"id": "fc1899af-acc5-406a-85c6-b9ea497a9b06",
"created_at": "2026-11-13T08:06:38.491636Z",
"company_name": "Delix Therapeutics",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/76400524",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*UC Davis Health Ventures' IFM Fund made a follow-on investment in Delix Therapeutics to advance Zalsupindole, an investigational oral medicine for major depressive disorder.*"
}